Symbol="ACOR"
AssetType="Common Stock"
Name="Acorda Therapeutics Inc"
Description="Acorda Therapeutics, Inc., a biopharmaceutical company, develops and markets therapies for neurological disorders in the United States. The company is headquartered in Ardsley, New York."
CIK="1008848"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="420 SAW MILL RIVER ROAD, ARDSLEY, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="21417100"
EBITDA="-2508000"
PERatio="None"
PEGRatio="0.51"
BookValue="63.24"
DividendPerShare="0"
DividendYield="0"
EPS="-40.53"
RevenuePerShareTTM="105.25"
ProfitMargin="-0.492"
OperatingMarginTTM="-0.292"
ReturnOnAssetsTTM="-0.0541"
ReturnOnEquityTTM="-0.569"
RevenueTTM="118290000"
GrossProfitTTM="82430000"
DilutedEPSTTM="-40.53"
QuarterlyEarningsGrowthYOY="5.87"
QuarterlyRevenueGrowthYOY="-0.012"
AnalystTargetPrice="10"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="0.108"
PriceToBookRatio="0.168"
EVToRevenue="1.497"
EVToEBITDA="-14.7"
Beta="1.432"
num_52WeekHigh="24.8"
num_52WeekLow="5.22"
num_50DayMovingAverage="13.46"
num_200DayMovingAverage="13.89"
SharesOutstanding="1216900"
DividendDate="2021-01-04"
ExDividendDate="None"
symbol="ACOR"
open="17.21"
high="17.51"
low="16.00"
price="16.50"
volume="11679.00"
latest_trading_day="2023-08-08"
previous_close="17.60"
change="-1.10"
change_percent="-6.2500%"
aroon_positive_momentum_days="63"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="TRUE"
Aroon_momentum="63"
Volume_recent_avg="543518"
Change_recent_avg="0.13"
Delta_recent_avg="0.58"
Variance_recent_avg="0.29"
Change_ratio_recent_avg="0.9"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="TRUE"
Aroon_momentum_positive="63"
Aroon_momentum_negative="37"
image_negative_thumbnail_id_1="488"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0117.jpeg"
image_negative_thumbnail_id_2="93"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0083.jpeg"
image_neutral_thumbnail_id_1="578"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_neutral_thumbnail_id_2="551"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_positive_thumbnail_id_1="657"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0051.jpeg"
image_positive_thumbnail_id_2="686"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0022.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
